Treatment with Vitamin D3 in Vitamin D Deficient Adolescents: A Pilot Study

Overview

Journal Glob Pediatr Health

Specialty Pediatrics

Date 2021 Jan 6

PMID 33403223

Citations 1

Authors

Mohan Kumaratne

Franck Vigneron

Jasmine Cisneros

Affiliations

Soon will be listed here.

Abstract

Multiple epidemiological studies have shown that vitamin D deficiency is highly prevalent amongst adolescents in the USA. However, recommendations regarding the treatment of vitamin D deficiency in healthy adolescents are not well defined. We carried out a prospective pilot study, to determine whether treatment with 2000 international units of vitamin D3 daily for 3 months, would normalize the vitamin D levels in vitamin D deficient adolescents. Following treatment there was a 56.02% increase in the vitamin D levels from the mean baseline values and 80.39% of the subjects normalized their vitamin D levels. There were no adverse effects associated with this intervention. This study offers complementary guidelines to the existing recommendations from the American Academy of Pediatrics on the optimal dose and duration of vitamin D3 therapy in vitamin D deficient, but otherwise healthy adolescents. Further prospective, large scale, case control studies are indicated to validate our results.

Citing Articles

Association between serum vitamin D levels and lipid profiles: a cross-sectional analysis.

Gholamzad A, Khakpour N, Kabipour T, Gholamzad M Sci Rep. 2023; 13(1):21058.

PMID: 38030665 PMC: 10687006. DOI: 10.1038/s41598-023-47872-5.

References

Gordon C, DePeter K, Feldman H, Grace E, Emans S . Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004; 158(6):531-7. DOI: 10.1001/archpedi.158.6.531. View

Aris R, Merkel P, Bachrach L, Borowitz D, Boyle M, Elkin S . Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab. 2004; 90(3):1888-96. DOI: 10.1210/jc.2004-1629. View

Talib H, Ponnapakkam T, Gensure R, Cohen H, Coupey S . Treatment of Vitamin D Deficiency in Predominantly Hispanic and Black Adolescents: A Randomized Clinical Trial. J Pediatr. 2015; 170:266-72.e1. PMC: 4769970. DOI: 10.1016/j.jpeds.2015.11.025. View

Rosen C, Abrams S, Aloia J, Brannon P, Clinton S, Durazo-Arvizu R . IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012; 97(4):1146-52. PMC: 5393439. DOI: 10.1210/jc.2011-2218. View

Khadilkar A, Khadilkar V, Chinnappa J, Rathi N, Khadgawat R, Balasubramanian S . Prevention and Treatment of Vitamin D and Calcium Deficiency in Children and Adolescents: Indian Academy of Pediatrics (IAP) Guidelines. Indian Pediatr. 2017; 54(7):567-573. DOI: 10.1007/s13312-017-1070-x. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Al-Aly Z, Qazi R, Gonzalez E, Zeringue A, Martin K . Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis. 2007; 50(1):59-68. DOI: 10.1053/j.ajkd.2007.04.010. View

Kaur P, Mishra S, Mithal A . Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency. Clin Endocrinol (Oxf). 2015; 83(3):327-31. DOI: 10.1111/cen.12836. View

Cross H, Bareis P, Hofer H, Bischof M, Bajna E, Kriwanek S . 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids. 2001; 66(3-5):287-92. DOI: 10.1016/s0039-128x(00)00153-7. View

10.

Mheid I, Quyyumi A . Vitamin D and Cardiovascular Disease: Controversy Unresolved. J Am Coll Cardiol. 2017; 70(1):89-100. DOI: 10.1016/j.jacc.2017.05.031. View

11.

Tsoukas C, Provvedini D, Manolagas S . 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984; 224(4656):1438-40. DOI: 10.1126/science.6427926. View

12.

Bhalla A, Amento E, Clemens T, Holick M, Krane S . Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983; 57(6):1308-10. DOI: 10.1210/jcem-57-6-1308. View

13.

Misgar R, Sahu D, Bhat M, Wani A, Bashir M . Vitamin D Toxicity: A Prospective Study from a Tertiary Care Centre in Kashmir Valley. Indian J Endocrinol Metab. 2019; 23(3):363-366. PMC: 6683682. DOI: 10.4103/ijem.IJEM_116_19. View

14.

Green D, Leonard A, Paranjape S, Rosenstein B, Zeitlin P, Mogayzel Jr P . Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients. J Cyst Fibros. 2010; 9(2):143-9. DOI: 10.1016/j.jcf.2010.01.002. View

15.

Borowitz D, Robinson K, Rosenfeld M, Davis S, Sabadosa K, Spear S . Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009; 155(6 Suppl):S73-93. PMC: 6324931. DOI: 10.1016/j.jpeds.2009.09.001. View

16.

Vogiatzi M, Jacobson-Dickman E, DeBoer M . Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab. 2014; 99(4):1132-41. DOI: 10.1210/jc.2013-3655. View

17.

Pittas A, Dawson-Hughes B, Sheehan P, Ware J, Knowler W, Aroda V . Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019; 381(6):520-530. PMC: 6993875. DOI: 10.1056/NEJMoa1900906. View

18.

Misra M, Pacaud D, Petryk A, Collett-Solberg P, Kappy M . Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008; 122(2):398-417. DOI: 10.1542/peds.2007-1894. View

19.

Tangpricha V, Flanagan J, Whitlatch L, Tseng C, Chen T, Holt P . 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001; 357(9269):1673-4. DOI: 10.1016/S0140-6736(00)04831-5. View

20.

Langman C, Mazur A, Baron R, Norman M . 25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity. J Pediatr. 1982; 100(5):815-20. DOI: 10.1016/s0022-3476(82)80602-1. View